India is the first to donate vaccines to Bangladesh and Bhutan

Editor : Lu Yongxin / https://www.ntdtv.com/gb/2021/02/14/a103054165.html / Direct translation

Image : The picture shows a health worker showing a vial of Covishield (AstraZeneca-Oxford's Chinese virus vaccine) at Patan Hospital near Kathmandu, Nepal, on January 27, 2021. (Prakash Mathema / AFP via Getty Images)

In the past, India was too careful in calculations, which led the CCP to favor the CCP through the “Belt and Road” initiative with the aid of infrastructure construction in South Asian countries. The Modi government has recently chanted the "neighbouring countries first" policy, using the CCP virus epidemic to prepare an anti-epidemic cooperation platform. After the two vaccines have been approved and mass-produced, they will be the first to donate to neighboring countries before the CCP. The CCP was so angry that people from all walks of life had doubts about vaccine transparency, and even wrote an article criticizing Bangladesh for rejecting China's vaccines to blame India.

The Central News Agency reported that the government of Nepal’s Prime Minister KP Sharma Oli, considered pro-China, rejected the CCP’s initiative to provide vaccines due to safety concerns, and turned to India for assistance. It also used 1 million doses donated by India from Oxford University, UK from January 27. The Covishield vaccine developed by AstraZeneca and manufactured by the Serum Institute of India (Serum Institute of India) was used to vaccinate all medical staff.

Oli publicly expressed his gratitude to India for donating vaccines; Nepal’s Minister of Health and Population, Hridayesh Tripathi, also stated that the Indian government expressed its goodwill through donating vaccines and showed a people-oriented spirit because the people are the Chinese Communist virus (COVID-19). , Wuhan pneumonia) the biggest victim of the epidemic.

Bangladesh, which has received a large amount of investment from the CCP in recent years, originally planned to donate 110,000 doses of vaccines to China. However, after Bangladesh refused to pay for vaccine research and development costs, China cancelled the donation plan, but India immediately accepted Bangladesh’s request and gave Bangladesh 2 million doses of vaccines for free.

In the past, many officials of the Modi government promoted the new citizenship law to deter illegal Muslim immigration from Bangladesh, which caused dissatisfaction in Bangladesh and gradually moved away from India. This time, India’s help has changed the situation.

The CCP has been trying to extend its power into Bhutan, and India has also donated 150,000 doses of vaccine to Bhutan to consolidate bilateral relations.

Among the countries in South Asia and the Indian Ocean region, it seems that only Pakistan, the "hard-core ally" of the CCP, is willing to accept vaccine donations from the CCP.

The Serum Institute of India is the world’s largest vaccine manufacturing company. With the production capacity of other pharmaceutical companies in India, the Indian government intends to provide 12 to 20 million doses of vaccine to neighboring countries in the near future. Modi has proudly said on many international occasions, India’s vaccines will soon be sent to countries around the world, saving more lives.

By quickly donating vaccines, India successfully fought a diplomatic victory that weakened the CCP’s influence in the Indian Ocean. The Global Times, the CCP media, criticized India’s intervention and interference in vaccine clinical trials in cooperation between the CCP and Bangladesh, leading to China in Bangladesh. Sinovac Biotech's vaccine clinical trial was postponed from July to October.

The Indian media reported that CanSino Biotech asked the Bangladesh government to pay for the local clinical trial costs of CanSino vaccine, which led Bangladesh to turn to India for vaccines. This led the Global Times to quote Chinese experts criticizing the Indian media for "smearing", but the Global Times article also admitted. Since CanSino Biotech could not afford the cost of clinical trials in Bangladesh, it asked Bangladesh to cooperate in sharing the cost.

An article on the “India News Network” stated that the Global Times seemed to ignore the fact that the opaque experimental methods used by these Chinese vaccine companies have caused some countries to react negatively and indifferently to vaccines developed and produced in China; Even in certain provinces of China, a large number of people refuse to administer the Chinese vaccine because they fear that the lack of transparency in production and experimentation will endanger their health.